Epigenetics and Tumorigenesis

Epigenetics and Human Health: Linking Hereditary, Environmental and Nutritional Aspects

Volumn , Issue , 2010, Pages 179-194

  Karlic, Heidrun ^a   Varga, Franz ^a  

^a HANUSCH HOSPITAL   (Austria)

Author keywords

Aging; Cancer; Epigenetic marks; Leukemia; Metabolic signaling; Myelodysplastic syndrome

Indexed keywords

EID: 77957779261     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527628384.ch15     Document Type: Chapter

References (78)

1. Wolffe, A.P. (2001) Chromatin remodeling: why it is important in cancer. Oncogene, 20, 2988-2990.
2. Ezzat, S. (2008) Chromatin remodeling: the interface between extrinsic cues and the genetic code? Clin. Invest. Med., 31, E272-E281.
3. Takahashi, H., McCaffery, J.M., Irizarry, R.A., and Boeke, J.D. (2006) Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol. Cell, 23, 207-217.
4. Ulrey, C.L., Liu, L., Andrews, L.G., and Tollefsbol, T.O. (2005) The impact of metabolism on DNA methylation. Hum. Mol. Genet., 14 (1), R139-R147.
5. Bird, A.W., Yu, D.Y., Pray-Grant, M.G., Qiu, Q., Harmon, K.E., Megee, P.C. et al. (2002) Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair. Nature, 419, 411-415.
6. Krebs, J.E., Fry, C.J., Samuels, M.L., and Peterson, C.L. (2000) Global role for chromatin remodeling enzymes in mitotic gene expression. Cell, 102, 587-598.
7. Masumoto, H., Hawke, D., Kobayashi, R., and Verreault, A. (2005) A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature, 436, 294-298.
8. Suka, N., Suka, Y., Carmen, A.A., Wu, J., and Grunstein, M. (2001) Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin. Mol. Cell, 8, 473-479.
9. Iizuka, M., and Smith, M.M. (2003) Functional consequences of histone modifications. Curr. Opin. Genet. Dev., 13, 154-160.
10. Roth, S.Y., Denu, J.M., and Allis, C.D. (2001) Histone acetyltransferases. Annu.Rev. Biochem., 70, 81-120.
11. James, S.J., Melnyk, S., Pogribna, M., Pogribny, I.P., and Caudill, M.A. (2002) Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr., 132, S2361-S2366.
12. Okano, M., Bell, D.W., Haber, D.A., and Li, E. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247-257.
13. Li, E., Bestor, T.H., and Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69, 915-926.
14. Pfeilstocker, M., Karlic, H., Nosslinger, T., Sperr, W., Stauder, R., Krieger, O. et al. (2007) Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications. Leuk. Lymphoma, 48, 1900-1909.
15. Holzenberger, M., Kappeler, L., and De Magalhaes Filho, C. (2004) IGF-1 signaling and aging. Exp. Gerontol., 39, 1761-1764.
16. Shimon, I., and Shpilberg, O. (1995) The insulin-like growth factor system in regulation of normal and malignant hematopoiesis. Leuk. Res., 19, 233-240.
17. Qi, H., Xiao, L., Lingyun, W., Ying, T., Yi-Zhi, L., Shao-Xu, Y. et al. (2006) Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis. Ann. Hematol., 85, 95-101.
18. Karlic, H., Lohninger, A., Laschan, C., Lapin, A., Bohmer, F., Huemer, M. et al. (2003) Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes. J. Mol. Med., 81, 435-442.
19. Pfeilstocker, M. (2006) Hypermethylation and reduced carnitine availability-a possible mechanism for downregulation of microsomal Carnitine Palmitoyltransferase (mCPT) in Myelodysplastic Syndromes (MDS). Blood, 85, 386-393.
20. Fillitz, M., Karlic, H., Tuchler, H., Zeibig, J., Spiegel, W., Wihlidal, P. et al. (2006) Does mRNA level of microsomal carnitine palmitoyltransferase predict yield of peripheral blood stem cell apheresis? Ann. Hematol., 85, 386-393.
21. Wilson, V.L., and Jones, P.A. (1983) DNA methylation decreases in aging but not in immortal cells. Science, 220, 1055-1057.
22. Casillas, M.A. Jr., Lopatina, N., Andrews, L.G., and Tollefsbol, T.O. (2003) Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts. Mol. Cell. Biochem., 252, 33-43.
23. Issa, J.P. (2003) Age-related epigenetic changes and the immune system. Clin. Immunol., 109, 103-108.
24. Kim, S.K., Jang, H.R., Kim, J.H., Kim, M., Noh, S.M., Song, K.S. et al. (2008) CpG methylation in exon 1 of transcription factor 4 increases with age in normal gastric mucosa and is associated with gene silencing in intestinal-type gastric cancers. Carcinogenesis, 29, 1623-1631.
25. Jiang, M.H., Fei, J., Lan, M.S., Lu, Z.P., Liu, M., Fan, W.W. et al. (2008) Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential. Diabetologia, 51, 1525-1533.
26. Shi, H., Wang, M.X., and Caldwell, C.W. (2007) CpG islands: their potential as biomarkers for cancer. Expert. Rev. Mol. Diagn., 7, 519-531.
27. So, K., Tamura, G., Honda, T., Homma, N., Waki, T., Togawa, N. et al. (2006) Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci., 97, 1155-1158.
28. Takatsu, M., Uyeno, S., Komura, J., Watanabe, M., and Ono, T. (1999) Age-dependent alterations in mRNA level and promoter methylation of collagen alpha1(I) gene in human periodontal ligament. Mech. Ageing Dev., 110, 37-48.
29. Bornman, D.M., Mathew, S., Alsruhe, J., Herman, J.G., and Gabrielson, E. (2001) Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am. J. Pathol., 159, 831-835.
30. Choi, E.K., Uyeno, S., Nishida, N., Okumoto, T., Fujimura, S., Aoki, Y. et al. (1996) Alterations of c-fos gene methylation in the processes of aging and tumorigenesis in human liver. Mutat. Res., 354, 123-128.
31. Kim, W.Y., and Sharpless, N.E. (2006) The regulation of INK4/ARF in cancer and aging. Cell, 127, 265-275.
32. Janzen, V., Forkert, R., Fleming, H.E., Saito, Y., Waring, M.T., Dombkowski, D.M. et al. (2006) Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature, 443, 421-426.
33. Esteller, M. (2007) Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum. Mol. Genet., 16 (1), R50-R59.
34. Holliday, R., and Grigg, G.W. (1993) DNA methylation and mutation. Mutat. Res., 285, 61-67.
35. Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev., 16, 6-21.
36. Gardiner-Garden, M., and Frommer, M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol., 196, 261-282.
37. Jones, P.A., and Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
38. Baylin, S.B., and Jones, P.A. (2007) Epigenetic determinants of cancer, in Epigenetics (eds C.D. Allis, T. Jenuwein, D. Reinberg, and M.-L. Caparros), Cold Spring Harbor Laboratory Press, New York, pp. 457-477.
39. Feinberg, A.P., and Vogelstein, B. (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature, 301, 89-92.
40. Esteller, M. (2003) Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv. Exp. Med. Biol., 532, 39-49.
41. Herman, J.G., and Baylin, S.B. (2003) Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med., 349, 2042-2054.
42. Knudson, A.G. (1996) Hereditary cancer: two hits revisited. J. Cancer Res. Clin. Oncol., 122, 135-140.
43. Knudson, A.G. (2001) Two genetic hits (more or less) to cancer. Nat. Rev. Cancer, 1, 157-162.
44. Galm, O., Herman, J.G., and Baylin, S.B. (2006) The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev., 20, 1-13.
45. Esteller, M., and Herman, J.G. (2002) Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol., 196, 1-7.
46. Hopkins-Donaldson, S., Ziegler, A., Kurtz, S., Bigosch, C., Kandioler, D., Ludwig, C. et al. (2003) Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ., 10, 356-364.
47. Hellwinkel, O.J., Kedia, M., Isbarn, H., Budaus, L., and Friedrich, M.G. (2008) Methylation of the TPEF-and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours. BJU Int., 101, 753-757.
48. Yang, H.J., Liu, V.W., Wang, Y., Tsang, P.C., and Ngan, H.Y. (2006) Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer, 6-212.
49. Bishton, M., Kenealy, M., Johnstone, R., Rasheed, W., and Prince, H.M. (2007) Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents. Expert. Rev. Anticancer Ther., 7, 1439-1449.
50. Herman, J.G., Civin, C.I., Issa, J.P., Collector, M.I., Sharkis, S.J., and Baylin, S.B. (1997) Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res., 57, 837-841.
51. Melki, J.R., Vincent, P.C., Brown, R.D., and Clark, S.J. (2000) Hypermethylation of E-cadherin in leukemia. Blood, 95, 3208-3213.
52. Lubbert, M., Mertelsmann, R., and Herrmann, F. (1997) Cytosine methylation changes during normal hematopoiesis and in acute myeloid leukemia. Leukemia, 11 (Suppl. 1), S12-S18.
53. Sakashita, K., Koike, K., Kinoshita, T., Shiohara, M., Kamijo, T., Taniguchi, S. et al. (2001) Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development. J. Clin. Invest., 108, 1195-1204.
54. Grady, W.M., Willis, J., Guilford, P.J., Dunbier, A.K., Toro, T.T., Lynch, H. et al. (2000) Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat. Genet., 26, 16-17.
55. Esteller, M., Fraga, M.F., Guo, M., Garcia-Foncillas, J., Hedenfalk, I., Godwin, A.K. et al. (2001) DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet., 10, 3001-3007.
56. Herman, J.G., Umar, A., Polyak, K., Graff, J.R., Ahuja, N., Issa, J.P. et al. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. U. S. A., 95, 6870-6875.
57. Dammann, R., Li, C., Yoon, J.H., Chin, P.L., Bates, S., and Pfeifer, G.P. (2000) Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet., 25, 315-319.
58. Burbee, D.G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B. et al. (2001) Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst., 93, 691-699.
59. Katzenellenbogen, R.A., Baylin, S.B., and Herman, J.G. (1999) Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood, 93, 4347-4353.
60. Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M.P. et al. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet., 31, 141-149.
61. Yamashita, K., Upadhyay, S., Osada, M., Hoque, M.O., Xiao, Y., Mori, M. et al. (2002) Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell, 2, 485-495.
62. Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev., 12, 599-606.
63. Fuks, F., Burgers, W.A., Brehm, A., Hughes-Davies, L., and Kouzarides, T. (2000) DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet., 24, 88-91.
64. Rountree, M.R., Bachman, K.E., and Baylin, S.B. (2000) DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet., 25, 269-277.
65. Espada, J., Ballestar, E., Fraga, M.F., Villar-Garea, A., Juarranz, A., Stockert, J.C. et al. (2004) Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J. Biol. Chem., 279, 37175-37184.
66. Bai, S., Ghoshal, K., Datta, J., Majumder, S., Yoon, S.O., and Jacob, S.T. (2005) DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2. Mol. Cell. Biol., 25, 751-766.
67. Kawai, H., Li, H., Avraham, S., Jiang, S., and Avraham, H.K. (2003) Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int. J. Cancer, 107, 353-358.
68. Macaluso, M., Cinti, C., Russo, G., Russo, A., and Giordano, A. (2003) pRb2/ p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer. Oncogene, 22, 3511-3517.
69. Choi, J.H., Kwon, H.J., Yoon, B.I., Kim, J.H., Han, S.U., Joo, H.J. et al. (2001) Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn. J. Cancer Res., 92, 1300-1304.
70. Halkidou, K., Gaughan, L., Cook, S., Leung, H.Y., Neal, D.E., and Robson, C.N. (2004) Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate, 59, 177-189.
71. Wilson, A.J., Byun, D.S., Popova, N., Murray, L.B., L ' Italien, K., Sowa, Y. et al. (2006) Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem., 281, 13548-13558.
72. Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Ando, Y., Mita, K. et al. (2005) Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast. Breast Cancer Res. Treat., 94, 11-16.
73. Huang, B.H., Laban, M., Leung, C.H., Lee, L., Lee, C.K., Salto-Tellez, M. et al. (2005) Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ., 12, 395-404.
74. Song, J., Noh, J.H., Lee, J.H., Eun, J.W., Ahn, Y.M., Kim, S.Y. et al. (2005) Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS, 113, 264-268.
75. Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.P., and Gottlicher, M. (2004) Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. C ancer Cell, 5, 455-463.
76. Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Omoto, Y., Ando, Y. et al. (2004) HDAC6 expression is correlated with better survival in breast cancer. Clin. Cancer Res., 10, 6962-6968.
77. Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M. et al. (2002) Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science, 295, 1079-1082.
78. Amann, J.M., Nip, J., Strom, D.K., Lutterbach, B., Harada, H., Lenny, N. et al. (2001) ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol. Cell Biol., 21, 6470-6483.